#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vascular malformation Non-small cell lung cancer recurrent Nephropathy Malignant central nervous system neoplasm Mucopolysaccharidosis I Diabetes insipidus Dementia Blood iron increased Thrombocytosis Brain stem glioma Immunodeficiency Sarcoma Muscular dystrophy Congenital nephrogenic diabetes insipidus Alternating hemiplegia of childhood More trials…

    Learn about Rare Diseases

    Cholangitis sclerosing – Treatment Amyotrophic lateral sclerosis – Trials in Disease Crigler-Najjar syndrome – Life with Disease Lennox-Gastaut syndrome Carcinoid syndrome – Diagnostics Lysosomal storage disorder – Life with Disease Rosai-Dorfman syndrome – Trials in Disease Lymphangiosarcoma – Basic Information Combined immunodeficiency – Life with Disease SAPHO syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cft1946 Cendakimab Pancreas Powder Trehalose Dihydrate (Ph.eur.) GSKVX000000040033 SODIUM FUSIDATE ANHYDROUS CALCIUM FOLINATE SALICYLIC ACID Metoprolol Tartrate Ht-29-B Ampicillin Enomimeran Acoramidis Hydrochloride Carisbamate GSKVX000000034798 Indometacin Bgb-15025 Citrate DISODIUM PHOSPHATE Fluvastatin Ck-0045 More therapies…

    Learn about Your Condition

    Metastasis Vaginal infection Chronic granulomatous disease Ependymoma Skin wrinkling Angiopathy Anaplastic thyroid cancer Peritonitis Staphylococcal infection Ulcerative keratitis Ewing's sarcoma metastatic Stress cardiomyopathy Oesophageal achalasia Hepatobiliary cancer Herpes zoster More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pancreatic carcinoma

  • Study on [68Ga]Ga-FAPI-46 PET/CT Imaging for Better Diagnosis in Patients with Pancreatic and Gastroesophageal Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    • Gastrooesophageal cancer
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    • Iodixanol
    Denmark

  • Study on Quemliclustat and Chemotherapy for Patients with Metastatic Pancreatic Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Quemliclustat
    • Saline
    • Gemcitabine
    Austria Belgium Czechia France Germany Italy +3

  • Study on Dostarlimab, Vitamin D3, and Drug Combination for Untreated Metastatic Pancreatic Cancer Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Colecalciferol
    • Dostarlimab
    • Fluorouracil
    France

  • Study on the Effects of Calcium Chloride and Bleomycin with Electroporation Techniques for Patients with Unresectable Pancreatic Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Bleomycin
    • Calcium Chloride Dihydrate
    Poland

  • Study of Nivolumab alone or combined with Ipilimumab for patients with advanced solid tumors (breast, gastric, pancreatic, lung, bladder, or ovarian cancer)

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    • Breast cancer
    • Bladder cancer
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    Germany

  • Study on Sonoporation-Enhanced Treatment with Gemcitabine, Nab-Paclitaxel, and FOLFIRINOX for Patients with Inoperable Pancreatic Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Perflubutane
    • Fluorouracil
    • Folinic Acid
    Norway
Previous Page
1 … 6 7 8 9 10
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!